Rare diseases
Investigational molecules
Locations
Back to Portugal51 clinical trials in Santa Maria Da Feira, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PortugalStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
PortugalStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
PortugalStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
PortugalStudy on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer
PortugalStudy on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis
PortugalStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
PortugalStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
PortugalStudy on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
PortugalStudy on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis
PortugalStudy on the Effects of Azetukalner in Reducing Focal-Onset Seizures for Patients with Epilepsy
PortugalStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Ongoing research evaluating novel treatments for multiple sclerosis and epilepsy, with studies focusing on both relapsing and progressive forms of MS, as well as various types of seizure disorders.
Multiple trials testing new compounds like tolebrutinib and fenebrutinib for long-term disease management.
Studies focusing on preventing cardiovascular events and managing atherosclerotic disease, with particular attention to high-risk patients and post-stroke care.
Innovative therapies being tested to reduce major adverse cardiovascular events and improve patient outcomes.
Research targeting inflammatory bowel diseases, including studies on Crohn's Disease and ulcerative colitis, testing new therapeutic approaches.
Evaluating combination therapies and novel compounds for moderate to severe disease states.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
